U.S. stock futures were lower this morning, with the Dow futures falling around 50 points on Wednesday.

Shares of Chewy, Inc. CHWY fell sharply in pre-market trading after the company reported quarterly earnings.

Chewy reported quarterly earnings of 28 cents per share which beat the analyst consensus estimate of 5 cents per share. The company reported quarterly sales of $3.25 billion which beat the analyst consensus estimate of $3.20 billion, according to data from Benzinga Pro.

Chewy shares declined 3.5% to $32.44 in the pre-market trading session.

Here are some other stocks moving lower in pre-market trading.

• Humacyte, Inc. HUMA shares fell 22.1% to $2.24 in pre-market trading after the company priced its $50 million public offering of 25 million common stock at $2.00 per share.
• Zhengye Biotechnology Holding Limited ZYBT shares tumbled 14.6% to $7.00 in pre-market trading after gaining 41% on Tuesday.
• Nyxoah S.A. NYXH fell 11.8% to $9.99 in today's pre-market trading. The FDA issued Nyxoah an approvable letter for its Genio® system.
• Rapport Therapeutics, Inc. RAPP fell 9.5% to $9.10 in pre-market trading.
• Oruka Therapeutics, Inc. ORKA shares fell 5% to $11.40 in pre-market trading.
• REGENXBIO Inc. RGNX fell 3.8% to $7.90 in pre-market trading.
• Rapport Therapeutics, Inc. RAPP declined 3.5% to $9.70 in pre-market trading.
• Perpetua Resources Corp. PPTA fell 3% to $10.87 in pre-market trading.
• Bausch Health Companies Inc. BHC slipped 2.4% to $6.83 in pre-market trading. Bausch Health announced the pricing of upsized private offering of senior secured notes.

Now Read This:

• Top 2 Health Care Stocks That Are Ticking Portfolio Bombs